ITM-91 by ITM Isotope Technologies Munich for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval

ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

Dec 31, 2024 - 06:00

ITM-91 is under clinical development by ITM Isotope Technologies Munich and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

Read the original article

Tags:

Previous Article

ITM-91 by ITM Isotope Technologies Munich for Metastatic Colorectal Cancer: Like...

Revolutionary Fish-Friendly Dentistry: Innovative Approach Advances Oral Researc...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

GUB-014295 by Gubra for Obesity: Likelihood of Approval

Dec 20, 2023

STAT+: Powerful Senate duo drops a bipartisan PBM reform plan

STAT+: Powerful Senate duo drops a bipartisan PBM refor...

Apr 21, 2023

Chinese NMPA approves AstraZeneca’s Calquence for leukaemia

Chinese NMPA approves AstraZeneca’s Calquence for leuka...

Sep 5, 2023